R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17

Abstract

In this update, we discuss a position statement from the National Institute of Health and Care Excellence (NICE) on the use of artificial intelligence for evidence generation and publications reviewing the use of real-world data as external control arms. Finally, we discuss a number of recent studies investigating the real-world effectiveness of glucagon-like peptide-1 receptor agonists and whether these studies are informative for reimbursement decision making.

Keywords

• artificial intelligence
• evidence generation
• external control arms
• glp-1ra
• health technology assessment
• natural language processing
• nice
• obesity
• real-world data
• real-world evidence